A new study published in Nanotechnology offers new hope for less harmful breast cancer therapy by combining two powerful, non ...

Switching to venetoclax led to sustained high rates of undetectable minimal residual disease, the investigators found.

Researchers identified a combination of two existing cancer drugs, letrozole and irinotecan, that reversed Alzheimer’s ...

Along with weight loss, Faubion’s study found that both groups of women on semaglutide drugs showed improvement in heart health measures like A1C (a marker for diabetes) and blood pressure, although ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

Tagrisso with chemo significantly improved survival and progression-free outcomes versus Tagrisso alone in newly diagnosed ...

Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

When standard cancer treatments begin to fail, especially in aggressive or advanced stages, oncologists are increasingly ...

City of Hope Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving ...

Alicia Morgans, MD, MPH, discusses how the ARANOTE trial not only demonstrated clinical efficacy for the combination of ADT and darolutamide, but also highlighted key quality-of-life benefits that ...